CTRI/2018/07/014830招募中未知
Comparative Evaluation Of Two Antiemetic Combination OF Palenosetron-Dexamethasone Versus Granisetron-Dexamethasone in Patients Undergoing Elective Laproscopic Surgery
Dr RPGMC TANDA0 个研究点目标入组 84 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 84
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients in the age group of 20-60 years.
- •1.ASA I â??II
- •2.Patient willing to give consent for study.
- •3.No history of motion sickness.
- •4.No previous history of PONV.
- •5.Nonsmoker.
排除标准
- •1.Patients not giving consent for study.
- •2.Patients with history of taking drugs responsible for antiemetic action for eg. steroids etc.
- •4.Patient with gastrointestinal reflux diseases.
- •5.Patient with history of PONV or motion sickness and those who had allergy to the study drugs or received antiemetic within 48 h before surgery.
- •6.Pregnancy and lactation.
- •7. Body mass index >35 kg/m2.
- •8.Patients with Baseline prolonged QTc interval.
- •9. Patients with electrolyte imbalances.
研究者
相似试验
已完成
2 期
Clinical evaluation of two antiemetic combinations palonosetron dexamethazone in paclitaxel and carboplatin: a randomized phase II trial.patients with gynecological malignancies who are receiving paclitaxel/carboplatin.JPRN-UMIN000007491ara Medical University80
招募中
3 期
Prophylactic antiemetic effects of Ondansetron and Haloperidol patients undergoing mastectomy- double-blind clinical trialIRCT20240224061097N1Iran University of Medical Sciences50
已完成
4 期
Combination Antiemetic Regimen for Prevention of PONV in Breast Surgery PatientsPostoperative Nausea and VomitingNCT00738621Scott and White Hospital & Clinic100
已完成
3 期
The efficacy of combination antiemetic therapy with Olanzapine, Palonosetron and dexamethasone for the prevention of nausea and vomiting in patients receiving Moderately Emetogenic Chemotherapygastric cancer, colorectal cancerJPRN-UMIN000034383Osaka Medical Collage150
已完成
不适用
Comparison of antiemetic effectiveness and safety of palonosetron and dexamethasone with palonosetron, dexamethasone and aprepitant in patients with lung cancer receiving combination therapy with carboplatin: A phase II randomized studylung cancerJPRN-UMIN000010056Hamamatsu University School of Medicine80
